secwatch.observer — SEC 8-K summary
======================================

Issuer:     Fresh Tracks Therapeutics, Inc. (—)
CIK:        0000819050
Form:       8-K
Filed at:   2023-12-18T23:59:59+00:00
Accession:  0001628280-23-041723
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Fresh Tracks Therapeutics to be suspended from Nasdaq on Dec 19; plans liquidation and dissolution
--------------------------------------------------------------------------------

- Stock to be suspended from Nasdaq at open on Dec 19, 2023; expects trading to begin on OTC market.
- Board withdrew appeal of Nasdaq delisting notice on Dec 15 in preparation for planned dissolution.
- Special meeting of stockholders reconvened for Dec 27 to vote on Plan of Liquidation and Dissolution.
- If stockholders do not approve dissolution, company intends to seek judicial dissolution, which would reduce cash distributions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/819050/000162828023041723/0001628280-23-041723-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/819050/000162828023041723/frtx-20231215.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-041723

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer